News | February 14, 2022
Divi’s Labs Q3 driven by custom synthesis; margins sustainable: ICICI Direct
Key takeaways of recent quarter & conference call highlights
Key takeaways of recent quarter & conference call highlights
Rimegepant is the first oral calcitonin gene-related peptide receptor antagonist to demonstrate positive results in a pivotal trial in the Asia Pacific
Expected to open later this year, the facility will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry
Laglo Soft lotion comes with a unique technology that enhances moisturisation and restructures the skin
It is being developed by Pune-based Gennova Biopharmaceuticals
It will showcase the company’s latest technologies in robotics, digital health and orthopaedic implants
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study. X-Chem's RosalindAI delivered superior and actionable results than other similar analyses using well-known publically available datasets
Adds five years of market exclusivity on approval
Subscribe To Our Newsletter & Stay Updated
